Discover Your Superpower with Omnipod® 5
Like the hero in our new Marvel comic, Dyasonic: Sound of Strength you too can simplify life with diabetes using Omnipod 5.
- No multiple daily insulin injections.
- No Tubes.
- Helps protect from highs lows1,2
- Shown to lower HbA1C1,2
Experience freedom from daily injections...
Omnipod is a small, wearable device that provides up to three days (72 hours) of continuous insulin delivery and eliminates the need for daily insulin injections. It’s virtually pain-free, and you can easily deliver insulin with the touch of a button - no need to see or handle an injection needle.
The sidekick that goes wherever you do.
Unlike traditional insulin pumps, there’s no tubes to get tangled, and no need to disconnect†, making it the perfect partner for all your adventures. And, the Pod is waterproof‡, so if those adventures include bathing, swimming, or other water-based activities, Omnipod 5 will be right there with you!
Always Adjusting So You Don’t Have To
The Omnipod 5 Pod works with your compatible Sensor to automatically adjust insulin delivery every 5 minutes to help keep you in range, day and night.1,2 And you control it all from your fingertips with the Omnipod 5 dedicated Controller.
Taking a screen break while you work on something awesome? You don’t need your Controller nearby** to receive continuous automated insulin delivery – the Pod and compatible Sensor have it handled with this fully wearable System!
The support you need to succeed
With Omnipod, you get more than just an insulin management system, you also get:
- Access to a 24/7 support team
- Training sessions and materials to get you started
- User guides, “how-to” videos, and resources to help along the way
- A community of Podders just like you, sharing tips and experiences for simplifying life with diabetes
When you get started on Omnipod, you have a team of dedicated support professionals and seemingly endless resources at your fingertips. It's our mission to help you simplify your diabetes management.
Try it for yourself
Nothing beats firsthand experience. The free Pod Experience Kit* (PEK) contains a needle-free nonfunctioning demo Pod for you to wear. It also includes a quick-start guide providing you with more information about the Omnipod System.
Talk to an Omnipod® Specialist
Still have more questions about the Omnipod® System? Enter your information below and one of our Omnipod® Specialists will call you in 24-48 hours for a one-to-one chat. Or you can call us direct at is 1800 954 075 (option 1 inside sales) if calling from abroad.
Risk Statement
The Omnipod 5 Automated Insulin Delivery System is a single hormone insulin delivery system intended to deliver U-100 insulin subcutaneously for the management of type 1 diabetes in persons aged 2 and older requiring insulin. The Omnipod 5 System is intended for single patient use. The Omnipod 5 System is indicated for use with NovoLog®/NovoRapid®, Humalog® / Liprolog®, Admelog® / nsulin lispro Sanofi®, Trurapi® / Insulin aspart Sanofi®, and Kirsty® U-100 insulin.
Refer to the Omnipod® 5 Automated Insulin Delivery System User Guide for complete safety information including indications, contraindications, warnings, cautions, and instructions.
WARNING: DO NOT start to use the Omnipod® 5 System or change settings without adequate training and guidance from a healthcare provider. Initiating and adjusting settings incorrectly can result in over-delivery or under-delivery of insulin, which could lead to hypoglycaemia or hyperglycaemia.
1. Brown S. et al. Diabetes Care (2021). Study in 240 people with T1D aged 6 - 70 years involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time with high blood glucose in adults/adolescents and children, standard therapy vs. 3-month Omnipod 5: 32.4% vs. 24.7%; 45.3% vs. 30.2%. Median time with low blood glucose in adults/adolescents and children, standard therapy vs. 3-mo Omnipod 5: 2.0% vs. 1.1%; 1.4% vs. 1.5%. Average A1c in adults/adolescents and children, standard therapy vs. Omnipod 5 = 7.16% vs 6.78%; 7.67% vs 6.99%. Average time (6AM-12AM) in Target Glucose range (from CGM) in adults/adolescents and children for standard therapy vs Omnipod 5 = 64.8% vs. 72.5%; 51.5% vs. 64.6%. Average time (12AM-6AM) in Target Glucose range (from CGM) in adults/adolescents and children for standard therapy vs Omnipod 5 = 64.3% vs. 78.1%; 55.3% vs. 78.1%. Study funded by Insulet.
2. Sherr JL, et al. Diabetes Care (2022). Study in 80 people with T1D aged 2 - 5.9 yrs involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time with high blood glucose from CGM in standard therapy vs Omnipod 5 = 39.4% vs. 29.5%. Average time with low blood glucose from CGM in standard therapy vs Omnipod 5 = 3.41% vs. 2.13%. Average A1c in standard therapy vs. Omnipod 5 = 7.4% vs. 6.9%. Average time in Target Glucose range (6AM-12AM) from CGM in standard therapy vs Omnipod 5 = 56.9% vs. 63.7%. Average time in Target Glucose range (12AM-6AM) from CGM in standard therapy vs. Omnipod 5 = 58.2% vs 81.0%. Study funded by Insulet.
**It’s recommended to keep the Controller close by to respond to any alerts or alarms.
†Device components must be removed (and the Pod and CGM sensor should be disposed of) before X-ray, Magnetic Resonance Imaging (MRI), or Computed Tomography (CT) scan (or any similar test or procedure). In addition, the Controller and smartphone should be placed outside of the procedure room. Exposure to X- ray, MRI, or CT, treatment can damage these components. Check with your healthcare provider on Pod removal guidelines.
‡ The Pod has an IP28 rating for up to 7.6 meters (25 feet) for 60 minutes. The Omnipod 5 Controller is not waterproof.
*The Pod Experience Kit is a non-functioning, needle free Pod, without the insulin. The Controller is not included.